Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice

Antiviral Research

Volumn 93, Issue 1, 2012, Pages 138-143

  Youn, Ha Na ^a   Lee, Dong Hun ^a   Lee, Yu Na ^a   Park, Jae Keun ^a   Yuk, Seong Su ^a   Yang, Si Yong ^b   Lee, Hyun Jeong ^b   Woo, Seo Hyung ^b   Kim, Hyoung Moon ^a   Lee, Joong Bok ^a   Park, Seung Yong ^a   Choi, In Soo ^a   Song, Chang Seon ^a  

^a Konkuk University   (South Korea)

^b CJ Cheiljedang   (South Korea)

Author keywords

Immunomodulation; Influenza virus; Lactobacillus; Mice; Probiotics

Indexed keywords

IMMUNOGLOBULIN A; INTERLEUKIN 12; INTERLEUKIN 6; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION PREVENTION; INFLUENZA A (H1N1); LACTOBACILLUS; LACTOBACILLUS BREVIS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL RATE;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; CHICK EMBRYO; CYTOKINES; FEMALE; IMMUNOGLOBULIN A; INFLUENZA A VIRUS, H1N1 SUBTYPE; LACTOBACILLUS; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PROBIOTICS;

LACTOBACILLUS; MUS; ORTHOMYXOVIRIDAE;

EID: 84355166769     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.11.004     Document Type: Article

References (29)

1. Boltz D.A., Aldridge J.R., Webster R.G., Govorkova E.A. Drugs in development for influenza. Drugs 2010, 70:1349-1362.
2. Botic T., Klingberg T.D., Weingartl H., Cencic A. A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria. Int. J. Food Microbiol. 2007, 115:227-234.
3. Dalloul R.A., Lillehoj H.S., Shellem T.A., Doerr J.A. Enhanced mucosal immunity against Eimeria acervulina in broilers fed a Lactobacillus-based probiotic. Poult. Sci. 2003, 82:62-66.
4. Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., Gubareva L.V., Xu X., Bridges C.B., Uyeki T.M. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 2009, 360:2605-2615.
5. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., Hoang D.M., Chau N.V., Khanh T.H., Dong V.C., Qui P.T., Cam B.V., Ha do Q., Guan Y., Peiris J.S., Chinh N.T., Hien T.T., Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 2006, 12:1203-1207.
6. Fensterl V., Sen G.C. Interferons and viral infections. Biofactors 2009, 35:14-20.
7. Galdeano C.M., Perdigón G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin. Vaccine Immunol. 2006, 13:219-226.
8. Giulietti A., Overbergh L., Valckx D., Decallonne B., Bouillon R., Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001, 25:386-401.
9. Harata G., He F., Hiruta N., Kawase M., Kubota A., Hiramatsu M., Yausi H. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett. Appl. Microbiol. 2010, 50:597-602.
10. Harikrishnan R., Balasundaram C., Heo M.S. Effect of probiotics enriched diet on Paralichthys olivaceus infected with lymphocystis disease virus (LCDV). Fish Shellfish Immunol. 2010, 29:868-874.
11. Hori T., Kiyoshima J., Shida K., Yasui H. Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice. Clin. Diagn. Lab. Immunol. 2001, 8:593-597.
12. Hori T., Kiyoshima J., Shida K., Yasui H. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin. Diagn. Lab. Immunol. 2002, 9:105-108.
13. Izumo T., Maekawa T., Ida M., Noguchi A., Kitagawa Y., Shibata H., Yasui H., Kiso Y. Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice. Int. Immunopharmacol. 2010, 10:1101-1106.
14. Kawase M., He F., Kubota A., Harata G., Hiramatsu M. Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection. Lett. Appl. Microbiol. 2010, 51:6-10.
15. Kobayashi N., Saito T., Uematsu T., Kishi K., Toba M., Kohda N., Suzuki T. Oral administration of heat-killed Lactobacillus pentosus strain b240 augments protection against influenza virus infection in mice. Int. Immunopharmacol. 2011, 11:199-203.
16. Kotani Y., Shinkai S., Okamatsu H., Toba M., Ogawa K., Yoshida H., Fukaya T., Fujiwara Y., Chaves P.H., Kakumoto K., Kohda N. Oral intake of Lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly: a randomized, placebo-controlled, double-blind trial. Immun. Ageing 2010, 7:11.
17. Liew F.Y., Russell S.M., Appleyard G., Brand C.M., Beale J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 1984, 14:350-356.
18. Maeda N., Nakamura R., Hirose Y., Murosaki S., Yamamoto Y., Kase T., Yoshikai Y. Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. Int. Immunopharmacol. 2009, 9:1122-1125.
19. Nishino M., Mizuno D., Kimoto T., Shinahara W., Fukuta A., Takei T., Sumida K., Kitamura S., Shiota H., Kido H. Influenza vaccine with Surfacten, a modified pulmonary surfactant, induces systemic and mucosal immune responses without side effects in minipigs. Vaccine 2009, 27:5620-5627.
20. Olivares M., Diaz-Ropero M.P., Gomez N., Lara-Villoslada F., Sierra S., Maldonado J.A., Martin R., Rodriguez J.M., Xaus J. The consumption of two new probiotic strains, Lactobacillus gasseri CECT 5714 and Lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans. Int. Microbiol. 2006, 9:47-52.
21. Sheu T.G., Fry A.M., Garten R.J., Deyde V.M., Shwe T., Bullion L., Peebles P.J., Li Y., Klimov A.I., Gubareva L.V. Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010. J. Infect. Dis. 2011, 203:13-17.
22. Son V.M., Chang C.C., Wu M.C., Guu Y.K., Chiu C.H., Cheng W. Dietary administration of the probiotic, Lactobacillus plantarum, enhanced the growth, innate immune responses, and disease resistance of the grouper Epinephelus coioides. Fish Shellfish Immunol. 2009, 26:691-698.
23. Takahashi E., Kataoka K., Fujii K., Chida J., Mizuno D., Fukui M., Hiro O.I., Fujihashi K., Kido H. Attenuation of inducible respiratory immune responses by oseltamivir treatment in mice infected with influenza A virus. Microbes Infect. 2010, 12:778-783.
24. Tang J.W., Shetty N., Lam T.T., Hon K.L. Emerging, novel, and known influenza virus infections in humans. Infect. Dis. Clin. North Am. 2010, 24:603-617.
25. Tsai Y.T., Cheng P.C., Liao J.W., Pan T.M. Effect of the administration of Lactobacillus paracasei subsp. paracasei NTU 101 on Peyer's patch-mediated mucosal immunity. Int. Immunopharmacol. 2010, 10:791-798.
26. Urdaci M.C., Bressollier P., Pinchuk I. Bacillus clausii probiotic strains: antimicrobial and immunomodulatory activities. J. Clin. Gastroenterol. 2004, 38:S86-90.
27. Wang S., Le T.Q., Kurihara N., Chida J., Cisse Y., Yano M., Kido H. Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J. Infect. Dis. 2010, 202:991-1001.
28. Webster D., Li Y., Bastien N., Garceau R., Hatchette T.F. Oseltamivir-resistant pandemic H1N1 influenza. CMAJ 2011, 183:E420-E422.
29. Yasui H., Kiyoshima J., Hori T. Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin. Diagn. Lab. Immunol. 2004, 11:675-679.